1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Agwa, A.J.
Schroeder, C.I.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
Biochim. Biophys. Acta
BBACAQ
0113
0006-3002
1859
835
844
10.1016/j.bbamem.2017.01.020
28115115
Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7.
2017
10.2210/pdb5tlr/pdb
pdb_00005tlr
4036.820
Mu-theraphotoxin-Hs2a
UNP residues 54-87
E56G, Y58W, F85W
1
syn
polymer
Mu-TRTX-Hs2a,Huwentoxin-4,Huwentoxin-IV,HwTx-IV,Huwentoxin-IVa,HWTX-IVa,Huwentoxin-IVb,HWTX-IVb,Huwentoxin-IVc,HWTX-IVc
no
yes
GCLGIWKACNPSNDQCCKSSKLVCSRKTRWCKWQI(NH2)
GCLGIWKACNPSNDQCCKSSKLVCSRKTRWCKWQIX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
entity
pdbx_audit_support
pdbx_audit_support
pdbx_nmr_software
pdbx_nmr_spectrometer
database_2
pdbx_database_status
repository
Initial release
Database references
Author supporting evidence
Structure summary
Author supporting evidence
Data collection
Database references
Other
1
0
2017-02-22
1
1
2017-03-01
1
2
2017-09-27
1
3
2020-01-08
1
4
2023-06-14
_entity.pdbx_number_of_molecules
_pdbx_audit_support.funding_organization
_pdbx_audit_support.funding_organization
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
Australia
National Health and Medical Research Council (NHMRC, Australia)
APP1080405
gHwTx-IV
N
RCSB
Y
RCSB
2016-10-11
REL
REL
REL
REL
29017
Chinese bird spider
Haplopelma schmidti
sample
1
36
all calculated structures submitted
50
20
isotropic
1
1D 1H
isotropic
1
2D 1H-1H TOCSY
isotropic
1
2D 1H-1H NOESY
isotropic
1
2D 1H-15N HSQC
isotropic
1
2D 1H-13C HSQC
isotropic
1
2D E.COSY
isotropic
1
2D 1H-1H TOCSY
isotropic
1
2D 1H-1H NOESY
isotropic
1
1D 1H
isotropic
2
2D 1H-1H TOCSY
isotropic
2
1D 1H
90
%
none
10
%
none
100
%
none
Not defined
gHwTx-IV_H2O
4.0
pH
ambient
298
K
Not defined
gHwTx-IV_D2O
4.0
pH
ambient
298
K
Temperature variation experiment with temperatures ranging from 283 - 308 K
Not defined
gHwTx-IV_Tempvar
4.0
pH
ambient
283
K
the structures are based on a total of 437 restraints, 385 are NOE-derived distance constraints, 10 distance restraints from hydrogen bonds, 42 dihedral angle restraints
torsion angle dynamics
1
fewest violations
90 % H2O, 10 % D2O, 90% H2O/10% D2O
gHwTx-IV_H2O
90% H2O/10% D2O
solution
100 % D2O, 100% D2O
gHwTx-IV_D2O
100% D2O
solution
Bruker Biospin
collection
TopSpin
CCPN
chemical shift assignment
CcpNMR
Guntert, Mumenthaler and Wuthrich
structure calculation
CYANA
Cornilescu, Delaglio and Bax
data analysis
TALOS-N
Brunger, Adams, Clore, Gros, Nilges and Read
refinement
CNS
Richardson
data analysis
MolProbity
Cryoprobe
600
Bruker
AVANCE
500
Bruker
AVANCE
GLY
1
n
1
GLY
1
A
CYS
2
n
2
CYS
2
A
LEU
3
n
3
LEU
3
A
GLY
4
n
4
GLY
4
A
ILE
5
n
5
ILE
5
A
TRP
6
n
6
TRP
6
A
LYS
7
n
7
LYS
7
A
ALA
8
n
8
ALA
8
A
CYS
9
n
9
CYS
9
A
ASN
10
n
10
ASN
10
A
PRO
11
n
11
PRO
11
A
SER
12
n
12
SER
12
A
ASN
13
n
13
ASN
13
A
ASP
14
n
14
ASP
14
A
GLN
15
n
15
GLN
15
A
CYS
16
n
16
CYS
16
A
CYS
17
n
17
CYS
17
A
LYS
18
n
18
LYS
18
A
SER
19
n
19
SER
19
A
SER
20
n
20
SER
20
A
LYS
21
n
21
LYS
21
A
LEU
22
n
22
LEU
22
A
VAL
23
n
23
VAL
23
A
CYS
24
n
24
CYS
24
A
SER
25
n
25
SER
25
A
ARG
26
n
26
ARG
26
A
LYS
27
n
27
LYS
27
A
THR
28
n
28
THR
28
A
ARG
29
n
29
ARG
29
A
TRP
30
n
30
TRP
30
A
CYS
31
n
31
CYS
31
A
LYS
32
n
32
LYS
32
A
TRP
33
n
33
TRP
33
A
GLN
34
n
34
GLN
34
A
ILE
35
n
35
ILE
35
A
NH2
36
n
36
NH2
36
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
VAL
23
A
N
VAL
23
A
O
LYS
32
A
O
LYS
32
6
A
A
OD1
HZ1
ASP
LYS
14
18
1.57
1
A
ASN
13
-150.38
75.51
1
A
GLN
15
-139.18
-75.90
1
A
CYS
16
51.32
-150.63
1
A
TRP
33
-106.84
-78.87
2
A
GLN
15
-140.55
-65.66
2
A
CYS
16
54.39
-151.05
3
A
GLN
15
-131.95
-59.47
3
A
CYS
16
51.52
-148.70
3
A
ARG
29
54.94
81.96
4
A
ASN
13
-150.98
88.96
4
A
GLN
15
-147.32
-71.19
4
A
CYS
16
52.12
-138.72
5
A
GLN
15
-133.20
-75.49
5
A
CYS
16
51.45
-146.50
5
A
ARG
29
50.92
79.75
6
A
GLN
15
-148.45
-75.02
6
A
CYS
16
56.27
-155.90
6
A
ARG
29
58.33
77.08
6
A
GLN
34
-179.40
-35.89
7
A
GLN
15
-128.57
-63.56
7
A
CYS
16
48.10
-156.41
7
A
THR
28
-150.23
-95.56
7
A
ARG
29
169.65
84.58
8
A
GLN
15
-140.57
-75.94
8
A
CYS
16
51.53
-145.34
8
A
ARG
29
61.49
85.64
8
A
TRP
30
-173.13
-179.30
9
A
GLN
15
-145.77
-75.59
9
A
CYS
16
53.24
-148.44
9
A
ARG
29
62.15
70.15
10
A
GLN
15
-123.42
-52.75
10
A
CYS
16
56.51
-148.53
10
A
LYS
21
63.96
61.42
11
A
ASN
13
-159.20
81.64
11
A
GLN
15
-135.64
-42.24
11
A
CYS
16
51.85
-148.73
11
A
ARG
29
63.22
63.84
11
A
GLN
34
-135.91
-42.91
12
A
GLN
15
-147.43
-75.79
12
A
CYS
16
50.97
-136.17
12
A
ARG
29
59.01
85.90
13
A
CYS
2
66.60
173.58
13
A
GLN
15
-152.68
-70.72
13
A
CYS
16
54.56
-142.15
13
A
LYS
21
67.42
61.33
13
A
ARG
29
57.94
77.12
14
A
CYS
2
65.02
173.79
14
A
GLN
15
-145.68
-67.69
14
A
CYS
16
55.11
-139.69
14
A
ARG
29
51.72
79.61
15
A
GLN
15
-139.70
-73.57
15
A
CYS
16
56.09
-152.92
15
A
LYS
21
70.69
49.29
15
A
GLN
34
-175.33
-27.48
16
A
GLN
15
-156.70
-75.37
16
A
CYS
16
50.72
-144.75
16
A
GLN
34
-73.75
-159.68
17
A
ASN
13
-152.87
73.13
17
A
GLN
15
-142.59
-75.79
17
A
CYS
16
51.87
-142.54
17
A
ARG
26
-96.93
-62.15
18
A
CYS
2
70.84
168.32
18
A
ASN
13
-153.80
83.71
18
A
GLN
15
-113.60
-72.32
18
A
CYS
16
53.32
-159.70
18
A
ARG
26
-104.41
-61.61
18
A
ARG
29
57.67
76.75
19
A
GLN
15
-134.33
-75.45
19
A
CYS
16
55.45
-150.14
19
A
THR
28
-150.38
-92.16
19
A
ARG
29
169.73
81.75
20
A
GLN
15
-133.94
-75.29
20
A
CYS
16
50.94
-146.92
20
A
ARG
29
58.13
75.04
refinement
CNS
N
Solution NMR structure of gHwTx-IV
1
N
N
disulf
2.030
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
17
A
SG
CYS
17
1_555
disulf
2.020
A
CYS
9
A
SG
CYS
9
1_555
A
CYS
24
A
SG
CYS
24
1_555
disulf
2.015
A
CYS
16
A
SG
CYS
16
1_555
A
CYS
31
A
SG
CYS
31
1_555
covale
1.300
both
A
ILE
35
A
C
ILE
35
1_555
A
NH2
36
A
N
NH2
36
1_555
TOXIN
spider toxin, disulfide-rich, sodium channel inhibitor, TOXIN
TXH4_HAPSC
UNP
1
54
P83303
CLEIFKACNPSNDQCCKSSKLVCSRKTRWCKYQI
54
87
5TLR
2
35
P83303
A
1
2
35
1
insertion
GLY
1
5TLR
A
P83303
UNP
1
1
GLU
engineered mutation
GLY
4
5TLR
A
P83303
UNP
56
4
1
PHE
engineered mutation
TRP
6
5TLR
A
P83303
UNP
58
6
1
TYR
engineered mutation
TRP
33
5TLR
A
P83303
UNP
85
33
1
amidation
NH2
36
5TLR
A
P83303
UNP
36
2
anti-parallel
A
VAL
23
A
VAL
23
A
CYS
24
A
CYS
24
A
CYS
31
A
CYS
31
A
LYS
32
A
LYS
32